‘‘(B) For a program that provides services 
to caregiver parents who are single parents and 
the sole caregivers with respect to their chil-
dren. 
‘‘(C) For a program that provides services 
to any caregiver parents. 
‘‘(2) PRIORITY FOR CERTAIN AREAS SERVED.— 
In making awards under subsection (a), the Director 
shall give priority to any entity, tribe, or organiza-
tion that agrees to use the award for a program 
serving an area that— 
‘‘(A) is an area determined by the Director 
to have a shortage of family-based substance 
abuse treatment options; or 
‘‘(B) is determined by the Director to have 
high rates of addiction to heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphet-
amine, or phencyclidine.’’; 
(13) in subsection (p)— 
(A) by striking ‘‘October 1, 1994’’ and in-
serting ‘‘January 1, 2013’’; 
(B) by striking ‘‘Committee on Labor and 
Human Resources’’ and inserting ‘‘Committee 
on Health, Education, Labor, and Pensions’’; 
and 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
(C) by striking the third sentence; 
(14) in subsection (q)— 
(A) by redesignating paragraphs (2), (3), 
(4), and (5) as paragraphs (3), (4), (5), and 
(6), respectively; 
(B) by inserting after paragraph (1) the 
following new paragraph: 
‘‘(2) The term ‘caregiver parent’ means, with 
respect to a child, a parent or legal guardian with 
whom the child resides, and includes a pregnant 
woman.’’; and 
(C) by amending paragraph (3), as redes-
ignated by subparagraph (A) of this paragraph, 
to read as follows: 
‘‘(3) The term ‘eligible caregiver parent’ means 
a caregiver parent who has been admitted to a pro-
gram operated pursuant to subsection (a).’’; and 
(15) in subsection (r), by striking ‘‘to fiscal 
years 2001 through 2003’’ and inserting ‘‘for fiscal 
years 2013 through 2017’’. 
SEC. 
5. 
EFFECTIVENESS 
OF 
STIMULANT 
TREATMENT 
METHODS. 
(a) RESEARCH.—The Director of the National Insti-
tute on Drug Abuse shall conduct research, directly or 
through contract with another entity, on the effectiveness 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
of the use of agonist and antagonist drugs to reduce the 
problems associated with stimulant abuse, including co-
caine and methamphetamine abuse. 
(b) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section for fiscal years 2013 
through 2017. 
SEC. 6. IOM STUDY ON DRUG TREATMENTS FOR STIMU-
LANT ABUSE. 
(a) REPORT.—The Secretary of Health and Human 
Services shall seek to enter into a contract with the Insti-
tute of Medicine of the National Academies to complete 
a literature review and submit a report to Congress on 
the effectiveness of agonist and antagonist drugs for the 
treatment of stimulant abuse, including cocaine and meth-
amphetamine abuse. 
(b) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section for fiscal years 2013 
through 2017. 
SEC. 7. GAO EVALUATION OF THE IMPACT OF THIS LEGIS-
LATION. 
(a) STUDY ON THE LEVEL OF FUNDING FOR TREAT-
MENT.—The Comptroller General of the United States 
shall conduct a study on— 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
(1) the impact of the programs authorized by 
this Act (including the amendments made by this 
Act) on the effectiveness and availability of treat-
ment for heroin, cocaine, methamphetamine, 3,4- 
methylenedioxymethamphetamine, and phencyclidine 
abuse; 
(2) whether the level of Federal funding avail-
able for the treatment of heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphetamine, 
and phencyclidine abuse meets, exceeds, or is less 
than the amount necessary to provide adequate 
treatment for such abuse; and 
(3) the impact of effective treatment of heroin, 
cocaine, methamphetamine, 3,4-methylenedioxymeth-
amphetamine, and phencyclidine abuse on cost sav-
ings due to the reduced need for criminal justice and 
other services. 
(b) REPORTS.— 
(1) INTERIM REPORT.—Not later than the last 
day of the two-year period beginning on the date of 
enactment of this Act, the Comptroller General shall 
submit to Congress a report on the interim findings 
of the study under subsection (a). 
(2) FINAL REPORT.—Not later than 3 years 
after the date on which the report under paragraph 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS
(1) is submitted to Congress, the Comptroller Gen-
eral shall submit to Congress a report on the find-
ings of the study under subsection (a). 
SEC. 8. FUNDING. 
(a) OFFSET.—Prior to being appropriated, additional 
amounts authorized by this Act shall be fully offset by a 
reduction to one or more other appropriations, as the 
House and Senate Committees on Appropriations consider 
appropriate. 
(b) BUDGET CONTROL ACT.—Nothing in this Act or 
the amendments made by this Act shall be interpreted to 
violate the budgetary caps enacted in the Budget Control 
Act of 2011 (Public Law 112–25). 
Æ 
VerDate Mar 15 2010 
22:54 May 14, 2012
Jkt 019200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6301
E:\BILLS\H5711.IH
H5711
srobinson on DSK4SPTVN1PROD with BILLS